Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Andrew Hore
twitter
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.
Premium
Highway Capital’s sporting chance
IPO Analysis
New standard listing: Harry Hyman TMT shell
Premium
Braveheart builds Autins stake
IPO Analysis
New AIM admission: Tortilla Mexican on the menu
IPO Analysis
New standard listing: Oxford Nanopore Technologies
Premium
FRC investigates audit of former AIM company subsidiary
Premium
Elliott Bernerd identifies value in Fletcher King
IPO Analysis
New standard listing: David Williams launches shell Bay Capital
IPO Analysis
New AIM admission: Made Tech’s digital potential
IPO Analysis
New AIM admission: Peel Hunt floats after profit peaks
Premium
LoopUp cash call at large discount
IPO Analysis
New AIM admission: GreenRoc Mining’s battery-powered prospects
Premium
Tip update: Transense progressing to profit
Premium
Exscientia set to propel Frontier IP NAV
Premium
Tip update: Holland deal opens up market for Maestrano
Premium
Demand recovers for Medica radiology services
IPO Analysis
New standard listing: Alkemy Capital seeks technology metals buy
Premium
Parity invests for recovery
Premium
Director Dealings: Parsley Box at a discount
Premium
More to SourceBio International than Covid-19 testing
Premium
Director dealings: Eleco bosses buy after strategy update
IPO Analysis
Marley on course for premium listing
Premium
Duke Royalty starts to invest cash pile
Premium
Semafone luanches lawsuit against PCI-Pal
Premium
Equals set for jump in profit
IPO Analysis
New Aquis admission: VSA Capital betting on Aquis
Premium
Buoyant US demand trebles Somero profit
Premium
Tip update: Long-term prospects still huge for Destiny Pharma
Premium
Alumasc surges ahead
Premium
Belvoir continues to prosper
Load more
Xpeng – the Tesla rival whose shares have rallied 315% in two months
23/11/2020
‘End of Austerity’ promise hashed out during PMQs
10/10/2018
Brexit: 5,000 City jobs could leave UK
10/10/2018
Advanced Oncotherapy shares soar after cancer treatment milestone
10/10/2018
Two reasons Travelodge backers can expect sleepless nights
24/07/2020